American Journal of Cancer

Chronic Myeloid Leukemia: The Value of Tyrosine Kinase Inhibition
pp. 305-311(7)
Authors: Tariq I. Mughal; John M. Goldman

Oncolytic Viruses for Cancer Therapy
pp. 313-323(11)
Author: Matthias Gromeier

Management of Testicular Germ Cell Tumors
pp. 325-334(10)
Authors: Robert A. Huddart; David P. Dearnaley; Alan Horwich

Promising New Approaches in the Treatment of Advanced Head and Neck Cancer
pp. 335-347(13)
Authors: Paul M. Harari; Gregory K. Hartig; Danny Rischin; Lester J. Peters

Docetaxel Plus Cisplatin: In NSCLC
pp. 349-356(8)
Authors: Toni M. Dando; Karen L. Goa

Docetaxel Plus Cisplatin: A Viewpoint by Chandra Belani and Sakkaraiappan Ramalingam
pp. 357-358(2)
Authors: Chandra Belani; Sakkaraiappan Ramalingam

Docetaxel Plus Cisplatin: A Viewpoint by Vassilis Georgoulias
pp. 357-358(2)
Author: Vassilis Georgoulias

Docetaxel plus Cisplatin: A Viewpoint by George Simon
pp. 357-358(2)
Author: George Simon

Pemetrexed
pp. 359-370(12)
Authors: Tracy Swainston Harrison; Lesley J. Scott

Pemetrexed: A Viewpoint by Mark McKeage and Timothy Christmas
pp. 371-372(2)
Authors: Mark McKeage; Timothy Christmas

Pemetrexed: A Viewpoint by Hedy L. Kindler
pp. 371-372(2)
Author: Hedy L. Kindler

Pemetrexed: A Viewpoint by Pieter E. Postmus
pp. 371-372(2)
Author: Pieter E. Postmus

Estramustine Phosphate Sodium: A Review of its Use in Combination Therapy for Hormone-Refractory Prostate Cancer
pp. 373-390(18)
Authors: Dene Simpson; Antona J. Wagstaff

Treatment Options for Chemotherapy-Induced Nausea and Vomiting: Current and Future
pp. 391-392(2)
Authors: Kevin J. Horgan; Kevin Petty; Anup Majumdar; Scott A. Reines; Judith K. Evans

The Author's Reply
pp. 392-392(1)
Author: Jens M. Stieler